Sidhu, A.; Khan, N.; Phillips, C.; Briones, J.; Kapoor, A.; Zalewski, P.; Fleshner, N.E.; Chow, E.; Emmenegger, U.
Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer. J. Clin. Med. 2023, 12, 5604.
https://doi.org/10.3390/jcm12175604
AMA Style
Sidhu A, Khan N, Phillips C, Briones J, Kapoor A, Zalewski P, Fleshner NE, Chow E, Emmenegger U.
Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer. Journal of Clinical Medicine. 2023; 12(17):5604.
https://doi.org/10.3390/jcm12175604
Chicago/Turabian Style
Sidhu, Amanjot, Nabeeha Khan, Cameron Phillips, Juan Briones, Anil Kapoor, Pawel Zalewski, Neil E. Fleshner, Edward Chow, and Urban Emmenegger.
2023. "Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer" Journal of Clinical Medicine 12, no. 17: 5604.
https://doi.org/10.3390/jcm12175604
APA Style
Sidhu, A., Khan, N., Phillips, C., Briones, J., Kapoor, A., Zalewski, P., Fleshner, N. E., Chow, E., & Emmenegger, U.
(2023). Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer. Journal of Clinical Medicine, 12(17), 5604.
https://doi.org/10.3390/jcm12175604
